Page last updated: 2024-10-28

lidocaine and Infections, Coronavirus

lidocaine has been researched along with Infections, Coronavirus in 2 studies

Lidocaine: A local anesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of PROCAINE but its duration of action is shorter than that of BUPIVACAINE or PRILOCAINE.
lidocaine : The monocarboxylic acid amide resulting from the formal condensation of N,N-diethylglycine with 2,6-dimethylaniline.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Aminnejad, R1
Salimi, A1
Saeidi, M1
Finnerty, DT1
Buggy, DJ1

Other Studies

2 other studies available for lidocaine and Infections, Coronavirus

ArticleYear
Lidocaine during intubation and extubation in patients with coronavirus disease (COVID-19).
    Canadian journal of anaesthesia = Journal canadien d'anesthesie, 2020, Volume: 67, Issue:6

    Topics: Airway Extubation; Anesthesiology; Betacoronavirus; Coronavirus; Coronavirus Infections; COVID-19; C

2020
A novel role for lidocaine in COVID-19 patients?
    British journal of anaesthesia, 2020, Volume: 125, Issue:4

    Topics: Anesthetics, Local; Coronavirus Infections; COVID-19; Cytokines; Extracellular Traps; Humans; Lidoca

2020